JANUS HENDERSON GROUP PLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Eyepoint, Inc. 13G
EYPT · 30233G209
 10.9% 9/8/2026
Event 8/31/2026
Vogenx, Inc. 13G
VOGX · 92859A106
 13.0% 9/8/2026
Event 8/31/2026
Teleflex Incorporated 13G/A Amendment 6
TFX · 879369106
 10.3% 9/8/2026
Event 8/31/2026
Ziff Davis, Inc. 13G/A Amendment 9
ZD · 48123V102
 10.3% 9/8/2026
Event 8/31/2026
Mirum Pharamaceuticals, Inc. 13G/A Amendment 10
MIRM · 604749101
 9.7% 8/13/2026
Event 6/30/2026
Forte Biosciences, Inc. 13G/A Amendment 5
FBRX · 34962G208
 9.3% 8/13/2026
Event 6/30/2026
Assembly Biosciences, Inc. 13G/A Amendment 1
ASMB · 045396207
 6.9% 8/13/2026
Event 6/30/2026
Tarsus Pharmaceuticals, Inc. 13G/A Amendment 1
TARS · 87650L103
 6.5% 8/13/2026
Event 6/30/2026
Dyne Therapeutics Inc 13G/A Amendment 7
DYN · 26818M108
 7.3% 8/13/2026
Event 6/30/2026
Protara Therapeutics, Inc. 13G/A Amendment 7
TARA · 74365U107
 8.4% 8/13/2026
Event 6/30/2026
Ziff Davis, Inc. 13G/A Amendment 8
ZD · 48123V102
 9.7% 8/13/2026
Event 6/30/2026
Icu Medical, Inc. 13G/A Amendment 12
ICUI · 44930G107
 11.1% 8/13/2026
Event 6/30/2026
Immix Biopharma, Inc. 13G/A Amendment 3
IMMX · 45258H106
 14.0% 8/13/2026
Event 6/30/2026
Janux Therapeutics, Inc. 13G/A Amendment 6
JANX · 47103J105
 0.3% 8/13/2026
Event 6/30/2026
Flex Ltd. 13G/A Amendment 8
FLEX · Y2573F102
 3.8% 8/13/2026
Event 6/30/2026
Bicara Therapeutics Inc. 13G/A Amendment 1
BCAX · 055477103
 4.8% 8/13/2026
Event 6/30/2026
Bel Fuse Inc. 13G/A Amendment 2
BELFB · 077347300
 4.8% 8/13/2026
Event 6/30/2026
Ocugen, Inc. 13G/A Amendment 1
OCGN · 67577C105
 3.0% 8/13/2026
Event 6/30/2026
Revolution Medicines, Inc. 13G
RVMD · 76155X100
 5.1% 8/13/2026
Event 6/30/2026
Achieve Life Sciences, Inc. 13G
ACHV · 004468500
 5.4% 8/13/2026
Event 6/30/2026
Inspired Entertainment, Inc. 13G
INSE · 45782N108
 5.0% 8/13/2026
Event 6/30/2026
LPL Financial Holdings Inc. 13G
LPLA · 50212V100
 5.3% 8/13/2026
Event 6/30/2026
Osi Systems, Inc. 13G
OSIS · 671044105
 5.5% 8/13/2026
Event 6/30/2026
Jatt II Acquisition Corp. 13G
JATT · G50765109
 6.2% 8/13/2026
Event 6/30/2026
Vaxcyte, Inc. 13G/A Amendment 11
PCVX · 92243G108
 12.1% 8/11/2026
Event 7/31/2026
Yarrow Bioscience, Inc. 13G
YARW · 92941V407
 10.0% 8/7/2026
Event 7/31/2026
Vaxcyte, Inc. 13G/A Amendment 10
PCVX · 92243G108
 0.1% 8/7/2026
Event 7/31/2026
Forte Biosciences, Inc. 13G/A Amendment 6
FBRX · 34962G208
 2.5% 8/7/2026
Event 7/31/2026
Privacore VPC Asset Backed Credit Fund 13G
74291E300
 17.1% 7/8/2026
Event 6/30/2026
Privacore Pcaam Alternative Growth Fund 13G
74290Y307
 46.8% 7/8/2026
Event 6/30/2026
Privacore Pcaam Alternative Income Fund 13G
74291A308
 67.4% 7/8/2026
Event 6/30/2026
Biohaven Ltd. 13G/A Amendment 2
BHVN · G1110E107
 5.7% 7/8/2026
Event 6/30/2026
Jade Biosciences, Inc. 13G/A Amendment 2
JBIO · 008064206
 10.6% 7/8/2026
Event 6/30/2026
Cellectar Biosciences, Inc. 13G
CLRB · 15117F880
 10.0% 6/5/2026
Event 5/29/2026
Immix Biopharma, Inc. 13G/A Amendment 2
IMMX · 45258H106
 13.0% 6/5/2026
Event 5/29/2026
Tyra Biosciences, Inc 13G/A Amendment 2
TYRA · 90240B106
 7.2% 5/15/2026
Event 3/31/2026
PTC Therapeutics, Inc. 13G/A Amendment 1
PTCT · 69366J200
 8.7% 5/15/2026
Event 3/31/2026
Protara Therapeutics, Inc. 13G/A Amendment 6
TARA · 74365U107
 9.6% 5/15/2026
Event 3/31/2026
Olema Pharmaceuticals, Inc. 13G/A Amendment 2
OLMA · 68062P106
 8.2% 5/15/2026
Event 3/31/2026
Lantheus Holdings, Inc. 13G/A Amendment 8
LNTH · 516544103
 7.4% 5/15/2026
Event 3/31/2026
Janux Therapeutics, Inc. 13G/A Amendment 5
JANX · 47103J105
 6.9% 5/15/2026
Event 3/31/2026
Jade Biosciences, Inc. 13G/A Amendment 1
JBIO · 008064206
 6.3% 5/15/2026
Event 3/31/2026
Immix Biopharma, Inc. 13G/A Amendment 1
IMMX · 45258H106
 9.1% 5/15/2026
Event 3/31/2026
Vaxcyte, Inc. 13G/A Amendment 9
PCVX · 92243G108
 11.5% 5/15/2026
Event 3/31/2026
Maze Therapeutics, Inc. 13G/A Amendment 3
MAZE · 578784100
 5.8% 5/15/2026
Event 3/31/2026
Madrigal Pharmaceuticals, Inc. 13G/A Amendment 9
MDGL · 558868105
 8.8% 5/15/2026
Event 3/31/2026
Ideaya Biosciences, Inc. 13G/A Amendment 6
IDYA · 45166A102
 8.3% 5/15/2026
Event 3/31/2026
Biohaven Ltd. 13G/A Amendment 2
BHVN · G1110E107
 11.7% 5/15/2026
Event 3/31/2026
Glaukos Corp 13G/A Amendment 1
GKOS · 377322102
 9.2% 5/15/2026
Event 3/31/2026
Gildan Activewear Inc 13G/A Amendment 4
GIL · 375916103
 5.7% 5/15/2026
Event 3/31/2026
Forte Biosciences, Inc. 13G/A Amendment 4
FBRX · 34962G208
 10.0% 5/15/2026
Event 3/31/2026
Dyne Therapeutics Inc 13G/A Amendment 6
DYN · 26818M108
 8.3% 5/15/2026
Event 3/31/2026
Bright Minds Biosciences Inc. 13G/A Amendment 4
DRUG · 10919W405
 13.1% 5/15/2026
Event 3/31/2026
Bright Minds Biosciences Inc. 13G/A Amendment 4
DRUG · 10919W405
 13.1% 5/15/2026
Event 3/31/2026
Bridgebio Pharma, Inc. 13G/A Amendment 1
BBIO · 10806X102
 6.8% 5/15/2026
Event 3/31/2026
Bel Fuse Inc. 13G/A Amendment 1
BELFB · 077347300
 7.2% 5/15/2026
Event 3/31/2026
Ascendis Pharma A/S 13G/A Amendment 9
ASND · 04351P101
 6.0% 5/15/2026
Event 3/31/2026
Minerva Neurosciences, Inc. 13G
NERV · 603380205
 9.9% 5/15/2026
Event 3/31/2026
Longeveron Inc. 13G
LGVN · 54303L203
 5.9% 5/15/2026
Event 3/31/2026
Bicara Therapeutics Inc. 13G
BCAX · 055477103
 5.1% 5/15/2026
Event 3/31/2026
Tarsus Pharmaceuticals, Inc. 13G
TARS · 87650L103
 5.3% 5/15/2026
Event 3/31/2026
Stride, Inc. 13G
LRN · 86333M108
 5.4% 5/15/2026
Event 3/31/2026
Edgewise Therapeutics, Inc. 13G
EWTX · 28036F105
 5.5% 5/15/2026
Event 3/31/2026
Collegium Pharmaceutical, Inc. 13G
COLL · 19459J104
 5.8% 5/15/2026
Event 3/31/2026
Dayforce, Inc. 13G/A Amendment 2
DAY · 15677J108
 0% 5/15/2026
Event 3/31/2026
Ardelyx, Inc. 13G/A Amendment 9
ARDX · 039697107
 3.4% 5/15/2026
Event 3/31/2026
Osi Systems, Inc. 13G/A Amendment 13
OSIS · 671044105
 4.7% 5/15/2026
Event 3/31/2026
Revolution Medicines, Inc. 13G/A Amendment 4
RVMD · 76155X100
 4.9% 5/15/2026
Event 3/31/2026
Xenon Pharmaceuticals Inc. 13G/A Amendment 1
XENE · 98420N105
 4.5% 5/15/2026
Event 3/31/2026
SS&C Technologies Holdings, Inc. 13G/A Amendment 14
SSNC · 78467J100
 3.5% 5/15/2026
Event 3/31/2026
Soleno Therapeutics, Inc. 13G/A Amendment 9
SLNO · 834203309
 2.3% 5/7/2026
Event 4/30/2026
Adagene Inc. 13G
ADAG · 005329107
 10.1% 5/7/2026
Event 4/30/2026
Promis Neurosciences Inc. 13G
PMN · 74346M505
 14.4% 4/7/2026
Event 3/31/2026
4D Molecular Therapeutics, Inc. 13G/A Amendment 1
FDMT · 35104E100
 10.3% 4/7/2026
Event 3/31/2026
Forte Biosciences, Inc. 13G/A Amendment 3
FBRX · 34962G208
 11.4% 2/17/2026
Event 12/31/2025
Gildan Activewear Inc 13G/A Amendment 3
GIL · 375916103
 5.7% 2/17/2026
Event 12/31/2025
SS&C Technologies Holdings, Inc. 13G/A Amendment 13
SSNC · 78467J100
 5.7% 2/17/2026
Event 12/31/2025
Flex Ltd. 13G/A Amendment 7
FLEX · Y2573F102
 6.0% 2/17/2026
Event 12/31/2025
Madrigal Pharmaceuticals, Inc. 13G/A Amendment 8
MDGL · 558868105
 7.0% 2/17/2026
Event 12/31/2025
Olema Pharmaceuticals, Inc. 13G/A Amendment 1
OLMA · 68062P106
 8.4% 2/17/2026
Event 12/31/2025
Dyne Therapeutics Inc 13G/A Amendment 5
DYN · 26818M108
 8.5% 2/17/2026
Event 12/31/2025
Lantheus Holdings, Inc. 13G/A Amendment 6
LNTH · 516544103
 8.6% 2/17/2026
Event 12/31/2025
Janux Therapeutics, Inc. 13G/A Amendment 4
JANX · 47103J105
 8.9% 2/17/2026
Event 12/31/2025
Protara Therapeutics, Inc. 13G/A Amendment 5
TARA · 74365U107
 10.0% 2/17/2026
Event 12/31/2025
Mirum Pharamaceuticals, Inc. 13G/A Amendment 7
MIRM · 604749101
 11.8% 2/17/2026
Event 12/31/2025
Soleno Therapeutics, Inc. 13G/A Amendment 8
SLNO · 834203309
 13.4% 2/17/2026
Event 12/31/2025
Cimpress PLC 13G/A Amendment 15
CMPR · G2143T103
 14.7% 2/17/2026
Event 12/31/2025
Bright Minds Biosciences Inc. 13G/A Amendment 3
DRUG · 10919W405
 14.9% 2/17/2026
Event 12/31/2025
Jade Biosciences, Inc. 13G
JBIO · 008064206
 6.2% 2/17/2026
Event 12/31/2025
Contineum Therapeutics, Inc. 13G
CTNM · 21217B100
 7.9% 2/17/2026
Event 12/31/2025
Immix Biopharma, Inc. 13G
IMMX · 45258H106
 7.4% 2/17/2026
Event 12/31/2025
Draftkings Inc. 13G
DKNG · 26142V105
 5.1% 2/17/2026
Event 12/31/2025
Glaukos Corp 13G
GKOS · 377322102
 5.3% 2/17/2026
Event 12/31/2025
Bridgebio Pharma, Inc. 13G
BBIO · 10806X102
 5.7% 2/17/2026
Event 12/31/2025
Bel Fuse Inc. 13G
BELFB · 077347300
 5.9% 2/17/2026
Event 12/31/2025
PTC Therapeutics, Inc. 13G
PTCT · 69366J200
 6.0% 2/17/2026
Event 12/31/2025
4D Molecular Therapeutics, Inc. 13G
FDMT · 35104E100
 8.1% 2/17/2026
Event 12/31/2025
Vistagen Therapeutics, Inc. 13G/A Amendment 1
VTGN · 92840H400
 0% 2/17/2026
Event 12/31/2025
Sensient Technologies Corporation 13G/A Amendment 13
SXT · 81725T100
 4.9% 2/17/2026
Event 12/31/2025
Metsera, Inc. 13G/A Amendment 1
MTSR · 59267L107
 3.1% 2/17/2026
Event 12/31/2025